Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07824817) titled 'Demedetomidine and Remifentanil in Electroconvulsive Therapy (ECT)' on Sept. 3.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).

Primary Sponsor: Inonu University

Condition: Hemodynamic Response

Intervention: Drug: Saline (0.9% NaCl) Drug: Dexmedetomidine

Recruitment Status: Not recruiting

Phase: Phase 4

Date of First Enrollment: September 21, 2026

Target Sample Size: 24

To know more, visit https://clinicaltrials.gov/study/NCT07824817

Disclaimer: Curate...